Protocatechuic acid inhibits lung cancer cells by modulating FAK, MAPK, and NF-κB pathways (Q38943879)

7 September 2017

Protocatechuic acid inhibits lung cancer cells by modulating FAK, MAPK, and NF-κB pathways (English)

1 reference

7 September 2017

0 references

1 reference

Shih-ming Tsao

1

1 reference

PubMed ID

25356681

7 September 2017

Te-chun Hsia

series ordinal

2

1 reference

PubMed ID

25356681

7 September 2017

Mei-chin Yin

series ordinal

3

1 reference

7 September 2017

30 October 2014

1 reference

7 September 2017

1 reference

7 September 2017

66

1 reference

7 September 2017

1331-1341

1 reference

7 September 2017

8

1 reference

Cancer epidemiology and control in Taiwan: a brief review

7 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Updates in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Synergistic cytotoxicity, inhibition of signal transduction pathways and pharmacogenetics of sorafenib and gemcitabine in human NSCLC cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Inhibition of cell proliferation, invasion and migration by ursolic acid in human lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Protocatechuic acid and human disease prevention: biological activities and molecular mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Bioavailability of strawberry antioxidants in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Bioavailability of various polyphenols from a diet containing moderate amounts of berries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Apoptotic effects of protocatechuic acid in human breast, lung, liver, cervix, and prostate cancer cells: potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Oleanolic acid initiates apoptosis in non-small cell lung cancer cell lines and reduces metastasis of a B16F10 melanoma model in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Characterization of the effects of cyclooxygenase-2 inhibition in the regulation of apoptosis in human small and non-small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Identification of multiple MAPK-mediated transcription factors regulated by tobacco smoke in airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

α-Tomatine suppresses invasion and migration of human non-small cell lung cancer NCI-H460 cells through inactivating FAK/PI3K/Akt signaling pathway and reducing binding activity of NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Berry anthocyanidins synergistically suppress growth and invasive potential of human non-small-cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Actein inhibits the Na+-K+-ATPase and enhances the growth inhibitory effect of digitoxin on human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Regulation and interplay of apoptotic and non-apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Alpha-mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via alphavbeta3 integrin/FAK/ERK and NF-kappaB signaling pathway in human lung adenocarcinoma A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

GHRH antagonist inhibits focal adhesion kinase (FAK) and decreases expression of vascular endothelial growth factor (VEGF) in human lung cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Riboflavin at high doses enhances lung cancer cell proliferation, invasion, and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

Targeting of the innate immunity/inflammation as complementary anti-tumor therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2014.956259

10.1080/01635581.2014.956259

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference

PubMed ID

25356681